Latest Articles
The Women’s Hospital Appoints Dr. Anjila Aneja to Lead Advanced Gynaecology, Robotic Surgery and Endometriosis Care - businessnewsthisweek.com
The Women’s Hospital Appoints Dr. Anjila Aneja to Lead Advanced Gynaecology, Robotic Surgery and Endometriosis Care businessnewsthisweek.com
Published: June 12, 2026, 10:51 a.m.
Hospital charity launches £1.5m MRI appeal to support 1,300 women and babies every year - Greater Birmingham Chambers of Commerce
Hospital charity launches £1.5m MRI appeal to support 1,300 women and babies every year Greater Birmingham Chambers of Commerce
Published: June 12, 2026, 5:07 a.m.
Medicus Pharma Submits Ind Application for PRECISION-E2 Phase 2A Study of Teverelix in Endometriosis in United Arab Emirates - marketscreener.com
Medicus Pharma Submits Ind Application for PRECISION-E2 Phase 2A Study of Teverelix in Endometriosis in United Arab Emirates marketscreener.com
Published: June 11, 2026, 1:52 p.m.
Oriva appoints Agnès Arbat as CEO as endometriosis drug enters clinic - The Pharma Letter
Oriva appoints Agnès Arbat as CEO as endometriosis drug enters clinic The Pharma Letter
Published: June 11, 2026, 12:10 p.m.
Medicus Pharma submits IND application for endometriosis trial By Investing.com - Investing.com Nigeria
Medicus Pharma submits IND application for endometriosis trial By Investing.com Investing.com Nigeria
Published: June 11, 2026, 11:58 a.m.
Medicus Pharma submits IND application for endometriosis trial - Investing.com
Medicus Pharma submits IND application for endometriosis trial Investing.com
Published: June 11, 2026, 11:55 a.m.
Medicus Pharma submits IND application for endometriosis trial By Investing.com - Investing.com Canada
Medicus Pharma submits IND application for endometriosis trial By Investing.com Investing.com Canada
Published: June 11, 2026, 11:41 a.m.
Medicus Pharma Ltd. Submits IND Application for Innovative PRECISION-E2 Phase 2a Clinical Trial in Endometriosis - Quiver Quantitative
Medicus Pharma Ltd. Submits IND Application for Innovative PRECISION-E2 Phase 2a Clinical Trial in Endometriosis Quiver Quantitative
Published: June 11, 2026, 11:41 a.m.
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline - The Manila Times
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline The Manila Times
Published: June 11, 2026, 7:39 a.m.
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline - GlobeNewswire
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline GlobeNewswire
Published: June 11, 2026, 7:30 a.m.
Link copied to clipboard!